Valuation : Safe Fertility Group

Market Cap 1.63B 49.47M 42.47M 39.76M 36.41M 68.58M 4.73B 68.78M 471M 184M 2.38B 186M 182M 7.88B P/E 2026 *
12.7x
P/E 2027 * 11.5x
Enterprise Value 1.63B 49.47M 42.47M 39.76M 36.41M 68.58M 4.73B 68.78M 471M 184M 2.38B 186M 182M 7.88B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.11x
Free-Float
23.1%
Yield 2026 *
6.92%
Yield 2027 * 7.48%
08-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-08 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-21 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-19 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 22, 2026 CI
11-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
07/08/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
07/05/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
30/04/25 Safe Fertility Group Public Company Limited Approves Dividend for the Year 2024, Payable on 23 May 2025 CI
20/02/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
20/02/25 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 23, 2025 CI
07/11/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
02/11/24 125,378,468 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2024. CI
07/08/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
1 day-0.93%
1 week-1.85%
Current month-1.85%
1 month-4.50%
3 months-10.17%
6 months-18.46%
Current year-16.54%
1 week 5.25
Extreme 5.25
5.4
1 month 5.25
Extreme 5.25
5.6
Current year 5.25
Extreme 5.25
6.9
1 year 5.25
Extreme 5.25
7.95
3 years 5.25
Extreme 5.25
23.7
5 years 5.25
Extreme 5.25
23.7
10 years 5.25
Extreme 5.25
23.7
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2007
Director of Finance/CFO 45 -
Chief Operating Officer 59 20/07/2009
Director TitleAgeSince
Director/Board Member 60 01/01/2007
Director/Board Member 59 20/07/2009
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap.
20/1/26 Buy

Chief Executive Officer

10,000 0.0033%
19/1/26 Buy

Chief Executive Officer

62,000 0.0204%
12/1/26 Buy

Chief Executive Officer

27,500 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-1.85%-28.38% - 49.51M
-0.84%-0.33%+29.77%+38.82% 121B
-1.27%+3.77%+4.08%+51.90% 92.48B
-0.53%-0.64%-1.44%+57.96% 30.41B
+0.78%+2.16%+37.14%+86.13% 27.04B
+0.42%+1.09%-1.23%-5.42% 22.37B
-2.04%-1.81%+47.11%+250.40% 22.08B
-0.17%+4.75%-6.18%+20.97% 14.92B
-0.57%-1.86%-7.24%-9.68% 12.46B
-0.27%+2.20%+30.20%+78.12% 11.48B
Average -0.54%+1.33%+10.38%+63.25% 35.39B
Weighted average by Cap. -0.72%+2.04%+17.25%+56.72%

Financials

2026 *2027 *
Net sales 698M 21.24M 18.23M 17.07M 15.63M 29.44M 2.03B 29.52M 202M 79M 1.02B 79.73M 78.01M 3.38B 772M 23.49M 20.16M 18.88M 17.28M 32.56M 2.24B 32.65M 224M 87.37M 1.13B 88.18M 86.28M 3.74B
Net income 128M 3.89M 3.34M 3.13M 2.87M 5.4M 372M 5.41M 37.06M 14.49M 187M 14.62M 14.31M 620M 142M 4.3M 3.7M 3.46M 3.17M 5.97M 411M 5.98M 40.97M 16.01M 207M 16.16M 15.81M 686M
Net Debt - -
Logo Safe Fertility Group
Safe Fertility Group Public Company Limited is a Thailand-based company engaged in providing an obstetrics and gynecology hospital. It is also engaged in the business of medical laboratory and cosmetic dermatology. The Company's segments are Obstetrics and Gynecology Hospital and Medical Laboratory, and Cosmetic Dermatology. Its services categories include In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI), Intrauterine Insemination (IUI), Egg Freezing, Embryo Transfer, Sperm Freezing, Sperm Analysis, Magnetic Activated Cell Sorting (MACS) Sperm, Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Testicular Sperm Extraction/Percutaneous Epididymal Sperm Aspiration (TESE/PESA), Couple Check-Up, EmbryoScope Plus, Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), and Acupuncture. The Company's subsidiaries include Next Generation Genomics Co., Ltd., and Safe Wellness Company Limited.
Employees
-
Date Price Change Volume
27/08/26 THB 5.350 0.00% 15,101
26/08/26 THB 5.350 +0.94% 103,500
25/08/26 THB 5.300 -0.93% 443,819
24/08/26 THB 5.350 +0.94% 76,437
21/08/26 THB 5.300 0.00% 281,250
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.350THB
Average target price
7.525THB
Spread / Average Target
+40.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SAFE Stock